Viral Filtration Market Size Worth US$ 21.8 billion With CAGR of 10% from 2022 to 2030
Pune, Dec. 19, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled, 'Viral Filtration Market Product (Consumable, Instruments, and Services), by Technology (Filtration,…

Pune, Dec. 19, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled, 'Viral Filtration Market Product (Consumable, Instruments, and Services), by Technology (Filtration, Chromatography), by Application (Biologicals, Stem Cell Products, Medical Devices, Water Purification, Air Purification), by End User (Biopharmaceuticals and Biotechnology, Contract Research Organisation, Medical Devices Company, and Academic Institutes and Research Laboratories) – Global Outlook & Forecast 2022-2030" published by Growth Plus Reports, the viral filtration market is expected to grow at a CAGR of 10% from 2021 to reach US$ 21.8 billion by 2030. Owing to increasing development in the pharmaceuticals industry and rising research and development activity are key driving factors.
Download PDF Brochure of viral filtration Market Size - COVID-19 Impact and Global Analysis with Strategic Developments at: URL
Market Drivers
The market is driven by rising single-use virus filtration system adoption, rising biopharmaceutical industry demand for viral filtering methods, and government assistance for the pharmaceutical and biotechnology sectors. The factors that are accelerating the growth of the global viral filtration market include the R&D sector's quick expansion, the biopharmaceutical industry's expanding capital availability, and rising government assistance. Due to the numerous clinical trials involving virus filtration that sought to identify methods for infection prevention, particularly to avoid community spread, the COVID-19 pandemic had a favourable effect on the virus filtration business. The main obstacles limiting the market's growth, however, are strict rules and regulations pertaining to the filtration of products and fierce rivalry among providers.
Excerpts from ‘By Type Segmentation'
Based on product, the global viral filtration market has been segmented into:
Consumable
Instruments
Services
The consumable is sub-segmented into kits and reagents and others whereas instruments is also sub-segmented into filtration system and chromatography system. The consumable segment dominated the market during forecast period. The reagents aid in lowering the chance of iatrogenic viral transmission. The reagents aid in determining the virus that is most likely to contaminate the cell substrate or any other reagents or materials employed in the procedure when evaluating the process. For reagents and kits for viral filtration, two well-known companies are Qiagen and Merck Millipore. Blood, plasma, serum, or other biological fluids, as well as any type of monoclonal antibody and recombinant proteins, may be utilised as samples in the manufacturing of biopharmaceuticals. Furthermore, even some pharmaceutical and biologic-based businesses have chosen to increase their R&D expenditures for vaccines, protein treatments, blood products, cellular therapy, gene therapy, tissue goods, and stem cell products. The market under study is being driven by the demand for these kits and reagents.
Excerpts from ‘By Region Segmentation'
Based on product, the global viral filtration market has been segmented into:
North America
Europe
Asia Pacific
Rest of the World
North America dominated the global market during forecast period. This is brought on by the rising prevalence of diseases and the expansion of the pharmaceutical industry in the area. The United States has the greatest market share in North America. Additionally, regulatory oversight of occurrences involving unintentional infections in manufacturing processes has expanded recently. The need for biologics is anticipated to boost the viral filtration market over the forecast period due to increased R&D by biopharmaceutical companies.
The viral filtration market in Europe is expected to grow as a result of technological developments, a growth in the use of biopharmaceuticals, and increased spending by major companies in R&D projects. The market in Asia Pacific is primarily being driven by the presence of favourable government laws, population growth, the availability of inexpensive labour, and the expansion of the manufacturing industry.
Excerpts from ‘Competitive Landscape'
Some of the prominent market players in the global viral filtrations market:
Merck KGaA
Asahi Kasei Corporation
BioProcess International
Sartorius AG
General Electric
Thermo Fisher Scientific, Inc.
General Electric Company
PendoTECH
Lonza
River Laboratories
Sotera Health
WuXi AppTec
The viral filteration market has a few significant competitors and is moderately competitive. Few of the top companies now control the industry under study in terms of market share. Few other minor competitors are anticipated to enter the market under study in the upcoming years due to the rising R&D of biopharmaceutical businesses and the high prevalence of disorders.
Request for Customization – URL
Table of Content
INTRODUCTION
Market Ecosystem
Timeline under consideration
Historical Years - 2020
Base Years - 2021
Forecasted Years: 2022-2030
Currency Used in the Report
RESEARCH METHODOLOGY
Research Approach
Methodology for Data Collection
Data Sources
Secondary sources
Primary Sources
Market Estimation Approach
Bottom Up
Top Down
Market Forecasting Model
Limitations and Assumptions
PREMIUM INSIGHTS
Current Market Trend (COVID-19 Perspective)
Key Players & Competitive Positioning (2021)
MARKET DYNAMICS
Drivers
Restraints/Challenges
Opportunities
GLOBAL VIRAL FILTRATIONMARKET - ANALYSIS & FORECAST, BY PRODUCT
Consumable
Kits and Reagents
Others
Instruments
Filtration System
Chromatography System
Services
GLOBAL VIRAL FILTRATION MARKET - ANALYSIS & FORECAST, BY TECHNOLOGY
Filtration
Chromatography
TOC Continued...
VALUE PROPOSITIONS RELATED TO THE REPORT:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Winning imperatives
Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
CUSTOMIZATION OPTIONS:
Distributor Landscape Assessment
Pricing Intelligence
Customer Base Assessment
Investment & Initiatives Analysis
'Business Profile' of Key Players
Directly Purchase Premium Copy of Viral Filtration Market Growth Report (2022-2030) at: URL
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.